Cargando…
The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study
BACKGROUND: Chronic use of proton-pump inhibitors (PPIs) is common in kidney transplant recipients (KTRs). However, concerns are emerging about the potential long-term complications of PPI therapy. We aimed to investigate whether PPI use is associated with excess mortality risk in KTRs. METHODS AND...
Autores principales: | Douwes, Rianne M., Gomes-Neto, António W., Eisenga, Michele F., Van Loon, Elisabet, Schutten, Joëlle C., Gans, Rijk O. B., Naesens, Maarten, van den Berg, Else, Sprangers, Ben, Berger, Stefan P., Navis, Gerjan, Blokzijl, Hans, Meijers, Björn, Bakker, Stephan J. L., Kuypers, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295199/ https://www.ncbi.nlm.nih.gov/pubmed/32542023 http://dx.doi.org/10.1371/journal.pmed.1003140 |
Ejemplares similares
-
Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019) -
Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019) -
Type of proton‐pump inhibitor and risk of iron deficiency in kidney transplant recipients – results from the TransplantLines Biobank and Cohort Study
por: Douwes, Rianne M., et al.
Publicado: (2021) -
Time-dependent variations in BK polyomavirus genome from kidney transplant recipients with persistent viremia
por: Mineeva-Sangwo, Olga, et al.
Publicado: (2023) -
Time to Cast the Prejudices Towards Transplantation of Kidneys Donated After Cardiac Death?
por: Van Loon, Elisabet, et al.
Publicado: (2018)